5.6.1 General remarks
Overview
5.6.1 General remarks
A revised version of this publication entered into force. |
Conventional antibodies are large, Y-shaped proteins naturally produced by plasma B-cells and composed of two identical light chains and two identical heavy chains, both containing variable and constant domains. Antibodies are designed by nature to bind specifically to antigen targets via the antigen binding region which contains complementarity-determining regions (CDRs).
Knowledge of the structure-function relationships of antibodies allows the provision of a number of derivatives for a multitude of applications. Variants of antibodies, antibody fragments, bispecific or multispecific antibodies, antibody fusion products are commonly designed and produced.
New antibody formats such as heavy-chain-only antibodies have also been developed. Compared with conventional antibodies, camelid heavy-chain-only antibodies consist of only two identical heavy chains (with variable and constant domains) and the antigen-binding region consists of a single variable domain with three CDRs.
Antibodies exist in a number of different formats. The most frequently used format is an immunoglobulin G (IgG), which is a large, Y-shaped protein composed of two identical light chains and two identical heavy chains, both containing variable and constant domains. Antibodies bind specifically to antigen targets via the antigen binding region which contains complementarity-determining regions (CDRs). In the case of an IgG, the antigen binding region consists of a heavy and light chain variable domain, each variable domain having three CDRs.
Other immunoglobulin structures are also known, such as heavy-chain-only antibodies that consist of only two identical heavy chains (with variable and constant domains) and the antigen-binding region consists of a single variable domain with only three CDRs.
Furthermore, knowledge of the structure-function relationships of parts of the antibody has allowed for the creation of antibody derivatives for a multitude of applications. These include antibody fragments, bispecific or multispecific antibodies and antibody fusion products.
In general, antibodies, i.e. conventional antibodies, recombinant antibody derivatives or new antibody formats can be defined by (but are not limited to):
(a)their own structure (amino acid sequences);
(b)nucleic acid sequences encoding the antibody;
(c)reference to the target antigen;
(d)target antigen and further functional features;